Business Context and Reporting Period
Company: vTv Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 17, 2020
Event: Unregistered Sales of Equity Securities (Item 3.02)
Key Financial Metrics
This filing reports a specific capital raise event rather than comprehensive financial statements. The following metrics are derived from the transaction disclosed:
- Capital Raised: $1.0 million
- Shares Issued: 625,000 shares of Class A common stock
- Price Per Share: $1.60
- Investor: MacAndrews & Forbes Group LLC
The filing text does not provide clear values for revenue, profit, cash flow, margins, total debt, or overall liquidity positions.
Material Changes
The material change reported is the execution of a purchase obligation under a letter agreement dated December 23, 2019. On December 17, 2020, the Company exercised its right to require the Investor to purchase the aforementioned shares, resulting in an immediate increase in cash and outstanding equity.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the transaction was executed pursuant to the terms of the December 2019 Letter Agreement. Definitive documentation was executed between the parties prior to funding.
Risks and Contingencies: The disclosure regarding the letter agreement is qualified in its entirety by reference to the agreement attached as Exhibit 10.25 to the Company's Annual Report on Form 10-K filed on February 21, 2020. No specific new risks or contingencies are detailed in this 8-K text.
Investor Verification Checklist
- Verify the terms of the December 23, 2019 Letter Agreement (Exhibit 10.25 to the 2020 10-K) to understand the full scope of the investment relationship.
- Confirm the impact of the 625,000 new shares on total outstanding share count and potential dilution.
- Review the Company's most recent 10-K or 10-Q for comprehensive liquidity and cash position data, as this 8-K only details the specific $1.0 million inflow.
- Check for any subsequent filings regarding the use of proceeds from this capital raise.